Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 was added to the history. Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the study record history. Removed the government-funding notice and Revision: v3.4.1 entry.SummaryDifference0.6%

- Check41 days agoChange DetectedA government funding lapse notice was added to the page, warning that data may not be up to date, and the revision version was updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check48 days agoChange DetectedGlossary visibility is added to the page, and UI highlights now color-code additions in green and deletions in red. The revision stamp updated to Revision: v3.4.0.SummaryDifference0.8%

- Check62 days agoChange DetectedNew entry Revision: v3.3.4 was added and Revision: v3.3.3 was removed from the Record History. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe record history now includes a new revision entry, Revision: v3.3.3, while the HHS Vulnerability Disclosure and the prior Revision: v3.3.2 entry were removed.SummaryDifference0.2%

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.